BDMD (Baird Medical Investment Holdings) EBIT per Share : $ (TTM As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings EBIT per Share?

Baird Medical Investment Holdings's EBIT per Share for the six months ended in Dec. 2023 was $0.36. Baird Medical Investment Holdings does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023.

During the past 12 months, the average EBIT per Share Growth Rate of Baird Medical Investment Holdings was -15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Baird Medical Investment Holdings's EBIT per Share or its related term are showing as below:

BDMD's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 6.1
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Baird Medical Investment Holdings's EBIT for the six months ended in Dec. 2023 was $12.65 Mil.

Baird Medical Investment Holdings EBIT per Share Historical Data

The historical data trend for Baird Medical Investment Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings EBIT per Share Chart

Baird Medical Investment Holdings Annual Data

Trend

Dec21

Dec22

Dec23

EBIT per Share

0.36

0.42

0.36

Baird Medical Investment Holdings Semi-Annual Data
	Dec21	Dec22	Dec23
EBIT per Share	0.36	0.42	0.36

Baird Medical Investment Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Baird Medical Investment Holdings's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	12.645	/	35.450
=	0.36

Baird Medical Investment Holdings's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	12.645	/	35.450
=	0.36

Baird Medical Investment Holdings (NAS:BDMD) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Baird Medical Investment Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN

Website

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Baird Medical Investment Holdings Headlines

From GuruFocus

Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference

By PRNewswire • 10-08-2024